Big Gain For Decibel Therapeutics Inc.
Wed, Jun 29, 2022 at 08:16 PM
Decibel Therapeutics Inc. (DBTX:NASDAQ) soared at $3.82, a gain of 44.2%. On Wed, Jun 29, 2022, DBTX:NASDAQ hit a New 2-Week High of $3.82. The stock got featured on our News Catalysts scanner on Tue, Jun 28, 2022 at 07:19 AM in the 'BIOTECH' category. From Wed, Jun 15, 2022, the stock recorded 77.78% Up Days and 60.00% Green Days
About Decibel Therapeutics Inc. (DBTX:NASDAQ)
Decibel Therapeutics Inc is a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments for hearing and balance disorders.
Top 10 Gainers:
- Allena Pharmaceuticals, Inc. (ALNA:NASDAQ), 114.29%
- Brickell Biotech, Inc. (BBI:NASDAQ), 47.64%
- Decibel Therapeutics Inc. (DBTX:NASDAQ), 44.15%
- Agrico Acquisition Corp. (RICO:NASDAQ), 43.66%
- Aeterna Zentaris Inc. (AEZS:NASDAQ), 39.98%
- Aditxt Inc. (ADTX:NASDAQ), 39.76%
- PARTS iD Inc. Class A (ID:NYSEMKT), 38.24%
- Avenue Therapeutics, Inc. (ATXI:NASDAQ), 32.04%
- Grove Collaborative Holdings Inc. Class A (GROV:NYSE), 29.45%
- 9F Inc. (JFU:NASDAQ), 28.01%